Home » News » Signing of the Cooperation Agreement with the LIFE BioCEEd Investment Fund

Signing of the Cooperation Agreement with the LIFE BioCEEd Investment Fund

November 6 2025

The Clinical Research and Translational Medicine Support Center (CR&TM SC) of the Wrocław University of Science and Technology has signed a cooperation agreement with the LIFE BioCEEd investment fund. A key role in the implementation of this agreement will be played by CR&TM SC, which will act as an intermediary between the LIFE BioCEEd investment fund and scientists.
The cooperation aims to strengthen the interaction between academic research and investment expertise to support the development and implementation of innovative biomedical projects. The partnership will focus on identifying promising scientific projects with potential health care applications, facilitating technology transfer from research environments to practical implementation, and providing scientists with access to advisory, translational and investment resources.
By combining the strong research base of the Wrocław University of Science and Technology with the investment experience and innovation network of LIFE BioCEEd, this cooperation represents an important step in bridging science and business in the field of biomedical innovation. It opens up new opportunities for commercializing academic discoveries and accelerating their transition to clinical and market applications.
CR&TM SC’s role as an intermediary is intended to support scientists in translating research outcomes into viable solutions, strengthening the ecosystem of research commercialization and expanding collaboration between academic institutions and the investment sector in Central and Eastern Europe.